By Drug Target Review2025-07-15T13:30:05
Researchers in Japan have developed long-lasting 3D liver organoids from stem cells by incorporating bile acids into the culture medium - offering a new model for studying chronic liver diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-11-20T13:43:43
Sponsored by Merck
2023-03-23T14:46:21
Sponsored by Bio-Techne
2024-01-10T08:23:16
Sponsored by BellBrook Labs
Site powered by Webvision Cloud